Enovix (NASDAQ:ENVX) Shares Down 4.2% – Here’s Why

Shares of Enovix Corporation (NASDAQ:ENVX) fell 4.2% during trading on Monday. The company traded as low as $2.41 and last traded at $2.3850. 1,169,735 shares were traded during mid-day trading, a decline of 83% from the average session volume of 6,804,836 shares. The stock had previously closed at $2.49.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $25.00 price target on shares of Enovix in a research note on Thursday, August 13th. Northland Securities set a $5.00 target price on Enovix in a research report on Tuesday, October 13th. TD Cowen raised Enovix to a “hold” rating in a research note on Monday, October 5th. Craig Hallum set a $7.00 price target on shares of Enovix in a research report on Thursday, August 13th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Enovix in a research note on Friday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Enovix currently has an average rating of “Moderate Buy” and an average price target of $10.77.

Enovix Stock Down 2.2%

The stock’s 50 day simple moving average is $3.18 and its two-hundred day simple moving average is $5.01. The firm has a market cap of $534.36 million, a P/E ratio of -2.99 and a beta of 2.49. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37.

Enovix (NASDAQ:ENVX) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The business had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 million. During the same period in the prior year, the firm posted ($0.13) EPS. The firm’s quarterly revenue was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, research analysts forecast that Enovix Corporation will post -0.79 earnings per share for the current year.

Hedge Funds Weigh In On Enovix

A number of institutional investors have recently bought and sold shares of ENVX. BlackRock Inc. bought a new stake in Enovix during the second quarter valued at about $100,054,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Enovix in the second quarter worth about $8,689,000. Bank of America Corp DE bought a new position in shares of Enovix in the second quarter worth about $8,356,000. Refined Wealth Management boosted its stake in shares of Enovix by 0.7% in the third quarter. Refined Wealth Management now owns 850,768 shares of the company’s stock worth $2,467,000 after acquiring an additional 5,918 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Enovix during the second quarter worth about $3,551,000. 50.92% of the stock is owned by institutional investors.

Enovix Company Profile

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.